This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pro Investors' Strategy Session for April

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Robert Auer, Auer Growth Fund

Auer, manager of the $228 million Auer Growth Fund (AUERX), says he's used to dealing with angry investors to begin the month of April. As a retail broker for 21 years at Morgan Stanley (MS), he saw the pains of tax season first hand.

"I was always cautious from April 1 until April 15 because tax season puts everyone in a bad mood," Auer says. "People who owe on taxes are typically wealthy and are stock investors, and sometimes they have to re-juggle their portfolio. If they didn't withhold enough, they need to get some money to pay. For that reason, I wouldn't be surprised to see the market stall out at this level."

Auer's investing strategy differs from other portfolio managers in that he only invests in companies with 25% increases in profits and 20% in revenue while also carrying a price-to-earnings ratio below 12. His portfolio has more than 100 stocks across all market caps.

After companies posted corporate earnings for the fourth quarter, Auer scratched many ideas off his list due to P/E ratios that grew too high. But he currently says that the bond market is "close to a tipping point," and that bond-scared money will come back into equities. "It will have no place to go. It could be huge, it could be explosive," he says.

Auer has had recent success with many of his stock picks. In September, he told TheStreet that he was investing in Micron (MU) and Marathon Oil (MRO), both of which are up 60% over the past six months. His fund also owned Cephalon (CEPH), which was recently acquired at a rich premium.

Looking ahead to April, Auer is a fan of Teva Pharmaceutical (TEVA - Get Report), which is a leading maker of generic drugs. The stock, which is currently Auer's largest position, is trading below a P/E ratio of 10 based on this year's earnings while it continues to grow at very high rates, Auer says. "For the risk/reward, it's fabulous at the $50 level," he adds. "We think the stock should be $100."

Veeco Instruments (VECO), a manufacturer of diodes for LED lighting, is "growing wildly," Auer says, as LED lighting becomes more popular. While he notes the stock is extremely volatile, he says it trades about 10 times this year's earnings and has "fantastic" growth potential.

-- Written by Robert Holmes in Boston.

>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to

>To submit a news tip, send an email to:

Readers Also Like:

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CNP $18.49 -0.32%
DE $78.46 0.32%
INTC $31.75 1.70%
LOW $71.19 -0.81%
TAP $81.00 -3.90%


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs